Provides high quality images at reduced dosage with the push of a button
Brings leadership experience in investing in, and developing, physicians
Lack of human oversight enhances fear of machine errors
Enhances support for imaging agent from private payors
Enhances adherence tracking based on NCCN guidelines
Cuts diagnostic exam time for the knee in half
Initiatives and challenges on the road to improving access to life saving treatment
How a quantitative method could improve dose optimization when scanning children
Why one expert believes efforts to lower imaging dose can actually do more harmful than good
Dr. Ashok Joseph Theruvath, postdoctoral research fellow in the Molecular Imaging Program at the Stanford School of Medicine discusses promising research for assessing pediatric chemo outcomes
Acquires surgery tech company, Orthotaxy, to develop new orthopedic platforms
Supports radiologists covering head, c-spine, chest and abdomen
Online retail giant sets sights on medical supply business
Facility is projected to become domestic source for Mo-99 production in US
Enables specialists to intervene before notified by a radiologist
Enabling faster access to supplies for diagnosis and treatment
Hazmat team called to the scene
Reduces time, costs and radiation exposure during spinal registration
First production process using non-uranium-based Mo-99
Driven by public and private investments, declining prices and analog reimbursement cuts
Could eye evaluations replace brain imaging for stroke assessment?
Billed for exams that never took place
Aiming to deploy system this year for about $40,000 per unit
Will be used to investigate neuronal disorders on the basis of glial biology
For treating NSCLC, the cutting edge option may not yield better outcomes
Equipment and building devastated by ISIS military offensive
Exams failed to meet ACR clinical image evaluation criteria
Could shorten measurement time to obtain anatomical images
Set to begin treating patients in September 2018
Treats non-melanoma skin cancers, keloids and superficial lesions
Company’s first investment in Australia and in Asia-Pacific
Administered contrast without proper physician supervision
Installing in the UAE, Oman and possibly India
Makes SyMRI software package available in its entirety in the US
First nonclinical research environment to use Exablate Neuro
Insider threats made up 37 percent of breaches
First to combine conventional HIS with AI and cloud computing
Marks entry into interventional oncology market
First used on January 27, 1968
Produces high-resolution images at low doses
Enables treatment of moving targets with proton therapy
First proton therapy center in Alabama
Policies deemed 'harmful' and likely to 'jeopardize' patient care
First patient treated on IBA Proteus Plus this week
Verifies planned radiation dose during ongoing treatments
Will pay settlement of over $1 million for fraud allegations
Suspended for another two years
Q&A with Ashley Simmons, director of innovation development at Florida Hospital
Purchasing choices are driven by the need for new and evolving features
Q&A with Dr. Christopher Longhurst, chief information officer UC San Diego Health
